ArticleResearch square2025
Endothelial defects unveil cardiovascular phenotype in iPSC-based disease modelling across three generations of a DiGeorge syndrome family.
Article in Research square, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
Abstract
DiGeorge syndrome (DGS) is caused by a microdeletion on chromosome 22, leading to variable disease phenotypes and severity and often involving congenital cardiovascular disease. In this work, we performed a detailed study of DGS patients with increasing severity within a family of three generations. Genetic analyses revealed no correlation between DGS severity and the size of the deletion or the number of overall genetic variants; however, we identified potentially high-impact variants, indicating a role for these genes in predisposition to the disease. For a phenotypic analysis, induced pluripotent stem cells (iPSCs) were generated and differentiated into functional cardiomyocytes and endothelial cells using blood cells from family members. In DGS patients, the iPSC-derived cardiomyocyte clusters during differentiation showed morphological differences in sarcomere arrangement along with lower cardiac connexin-43 expression. These findings indicate an impaired structural development due to an altered expression of gap junction proteins and cardiomyocyte-matrix connections as a basis of cardiovascular pathology. In endothelial cells differentiated from iPSCs of the DGS patients, we found an aberrant vascular phenotype. Vascular defects were observed in differentiation and migration, as well as in endothelial tubular morphology, accompanied by altered transcription patterns for angiogenesis and vascular integrity pathways. These results suggest that DGS-specific cell types differentiated from hiPSC show major alterations and may be used to uncover genotype-phenotype correlations with the potential to reveal the molecular basis of the clinical manifestations in DGS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.